Press
Molecular diagnostics company oncgnostics GmbH closes Series A financing round for CE mark and market entry of its cervical cancer diagnostics test GynTect®
oncgnostics develops, based on proprietary epigenetic biomarkers molecular tests for reliable cancer diagnostics. With the seed financing through High-tech Gruenderfonds (HTGF) and Stiftung fuer Technologie, Innovation und Forschung Thueringen (STIFT), oncgnostics implemented a quality management system and developed its first test GynTect®. This test allows reliable diagnostics of cervical cancer and its pre-stages. Now oncgnostics has raised a seven-digit Euro amount in a Series A financing r
Portfolio
Implisense
Implisense offers a solution for lead generation as well as cross- and upselling for B2B marketing and sales. Their self-developed company index, which is kept up-to-date on a day-to-day basis and stores information about several million companies in Germany is the foundation of their solution. Users can obtain access to this index via a Web-based interface and perform their own customer and market analysis. The solution can compute a target profile based on examples of a user’s existing custo
Press
Europe’s leading online optician strengthens market position: Mister Spex receives 40 Million USD
US bank Goldman Sachs leads financing round
Europe’s leading online optician Mister Spex concludes its largest financing to date raising 40 Million USD in a round led by US investment bank Goldman Sachs with participation from existing investors including Scottish Equity Partners, XAnge and DN Capital. Funds will be used to support the Company’s domestic and international growth plans.
"The current round of financing is the best confirmation of our consistent and successful pioneering
Press
High-Tech Gründerfonds expands management team: Partner Romy Schnelle made Managing Director
Bonn, 8th May 2023 – The Investor Advisory Board has appointed Romy Schnelle (44) as a Managing Director of High-Tech Gründerfonds (HTGF). Together with Dr. Alex von Frankenberg and Guido Schlitzer, she is responsible for managing one of Europe’s leading seed investors. HTGF launched its fourth fund in February and now manages around €1.4 billion of capital in total. With around €500 million in this fund, HTGF can invest even more capital in each start-up.
Romy Schnelle h
Blog
Our mission? To help more people!
Cervical cancer is the most common type of cancer of the female genital organs. In Germany, there are more than 4,600 new cases of women affected by this tumour each year, according to the German Cancer Society (DKG). Conventional testing procedures are very unreliable. The team at HTGF portfolio company oncgnostics has therefore developed GynTect, a procedure that considerably improves the diagnosis of cervical cancer. The product was recently also approved in China – an important milesto
Press
PraxisEins – Strategic capital increase by HTGF and Hessen Kapital
Frankfurt am Main, 28.11.2023 – The state-supported practice network PraxisEins is receiving a further strategic capital increase from High-Tech Gründerfonds (HTGF), bmh Beteiligungs-Managementgesellschaft Hessen (via the Hessen Kapital I fund) and market expert investors. The Frankfurt-based company makes it easier for doctors to enter the field of outpatient care, thereby addressing the impending shortage of GPs. The new capital will be deployed to further develop the company’
Press
Worldwide First – Professional Real Estate Software “In the Clouds”
The developer of the leading Software-as-a-Service (SaaS) platform for real estate sales, Propertybase GmbH, has successfully closed their first financing package. Based on their early success and profitable track record, Propertybase has secured investments from Bayern Kapital and Neuhaus Partners, while start-up investor High-Tech Gründerfonds will support the company as lead investor.
Propertybase is the first company to develop a complete front-and-back-office sales, marketing, and servi
Press
Synoste Oy raises € 2.8 M in financing to Develop Next-Generation implants for correcting skeletal deformities
Synoste Oy, a Helsinki and Düsseldorf based medical device company is developing next-generation implantable devices based on their unique and proprietary technology platform. The company has now raised a seed-round of € 0.8 M to advance the development of its first product aimed at the limb lengthening market. The seed round can be increased up to € 1.2 M upon reaching certain milestones and is supported by TEKES research funding with additional approx. € 1.6 M. High-Tech Gründerfonds
Press
CorTec On The Way To The Future Of Neurotechnology: Company Closes Second Financing Round
Just two years after seed financing CorTec announces the closing of another round of investment. M-Invest and KfW banking group are now joining the round of investors engaged with CorTec. Their investment of three million Euro will support the market launch of AirRay, CorTec’s first product. Furthermore, the company plans to start into the clinical phase with the implant based on CorTec Brain Interchange technology.
„With M-Invest we found a very active investor who gives us great support
Press
Compositence GmbH Secures Further Growth Through Capital Increase
Compositence GmbH, specializing in solutions for cost-effective serial production using carbon and glass fibers, has acquired an increase in capital. The company has gained Zukunftsfonds Heilbronn as a new lead investor; the holding company Mittelständische Beteiligungsgesellschaft Baden-Württemberg (MGB) and venture capitalist High-Tech Gründerfonds are contributing further capital.
The innovation of Compositence is a production process with which components made of high-performance fiber
Press
CryoTherapeutics GmbH completes Second Closing of Series A Financing Round with a total volume of €3 million and adds Charité Biomedical Fund as investor
CryoTherapeutics GmbH (CryoTherapeutics), the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease, announced today that it has completed a second closing of its Series A financing round, with Peppermint VenturePartners (PVP) via its new Charité Biomedical Fund joining the investor consortium. The additional investment by PVP is in addition to the Series A financing round closed in June 2012 by NRW.BANK, High-Tech Gründerfonds (HTGF), private invest
Portfolio
Skoove
Skoove makes music education fun, effective and accessible for everybody. With Skoove's interactive apps anyone can learn to play piano and guitar. Go to www.skoove.com and join the interactive online piano courses.
Press
Growth capital for WeSustain (Series B)
WeSustain, a software company with focus on Enterprise Sustainability Management, today announces that a new financing round of € 4 Mill. has been successfully closed. Companies like Daimler, Allianz or Commerzbank deploy WeSustain’s cloud-based software solution for their sustainability reporting. Deutsche Telekom is a strategic partner of WeSustain.
The EU recently issued a new legislative directive, which makes sustainability reporting mandatory for large enterprises. As a result signi
Press
MedTech startup Smarterials Technology closes second seed financing round
MedTech startup Smarterials Technology GmbH has successfully closed its second round of financing. Led by High-Tech Gründerfonds (HTGF), pre-seed investors Think.Health Ventures and Emanet also invest a total of nearly €1 million in the Berlin-based company. The new funding will be used to complete final development steps and prepare production for the mass market.
Berlin, 28.09.2021 – Smarterials Technology develops surgical gloves based on innovative materials with a double barrier
Press
EnerNOC Acquires Leading European Demand Response Company Entelios AG
EnerNOC, Inc. (Nasdaq:ENOC), a leading provider of energy intelligence software (EIS), today announced that it has acquired Entelios AG, a leading provider of demand response in Europe. This acquisition accelerates EnerNOC’s entry into continental Europe with Entelios’ strong team and existing relationships with leading grid operators, utilities, retailers, and commercial, institutional, and industrial customers.
In 2010 High-Tech Gruenderfonds (HTGF) invested in Entelios. Together
Press
High-Tech Gründerfonds and STIFT invest into molecular cancer diagnostics from Jena
Oncgnostics GmbH obtains seed funding for financing preclinical and clinical trials.
Chemical alterations of the genetic information specifically occuring during carcinogenesis provide the basis for the innovative diagnostic tests that are developed by the newly established oncgnostics GmbH in Jena. These tests allow not only for an earlier, but also a more accurate detection of cancer cases. An early detection by highly specific and sensitive tests is a prerequisite for successful cancer tre